- Home
- ALVO vs ARDT Comparison
ALVO vs ARDT Comparison
Compare ALVO & ARDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVO
- ARDT
- Stock Information
- Founded
- ALVO 2013
- ARDT 2001
- Country
- ALVO Luxembourg
- ARDT United States
- Employees
- ALVO N/A
- ARDT N/A
- Industry
- ALVO Biotechnology: Pharmaceutical Preparations
- ARDT
- Sector
- ALVO Health Care
- ARDT
- Exchange
- ALVO Nasdaq
- ARDT NYSE
- Market Cap
- ALVO 2.5B
- ARDT 2.1B
- IPO Year
- ALVO N/A
- ARDT 2024
- Fundamental
- Price
- ALVO $11.44
- ARDT $14.46
- Analyst Decision
- ALVO Buy
- ARDT Buy
- Analyst Count
- ALVO 1
- ARDT 13
- Target Price
- ALVO $18.00
- ARDT $20.77
- AVG Volume (30 Days)
- ALVO 291.4K
- ARDT 309.7K
- Earning Date
- ALVO 05-07-2025
- ARDT 05-06-2025
- Dividend Yield
- ALVO N/A
- ARDT N/A
- EPS Growth
- ALVO N/A
- ARDT 935.52
- EPS
- ALVO 0.34
- ARDT 1.64
- Revenue
- ALVO $587,890,000.00
- ARDT $6,024,260,000.00
- Revenue This Year
- ALVO $22.17
- ARDT $8.18
- Revenue Next Year
- ALVO $58.38
- ARDT $5.53
- P/E Ratio
- ALVO $33.75
- ARDT $8.84
- Revenue Growth
- ALVO 413.92
- ARDT 8.91
- 52 Week Low
- ALVO $7.35
- ARDT $11.31
- 52 Week High
- ALVO $14.65
- ARDT $20.72
- Technical
- Relative Strength Index (RSI)
- ALVO 68.73
- ARDT N/A
- Support Level
- ALVO $9.60
- ARDT N/A
- Resistance Level
- ALVO $11.57
- ARDT N/A
- Average True Range (ATR)
- ALVO 0.48
- ARDT 0.00
- MACD
- ALVO 0.17
- ARDT 0.00
- Stochastic Oscillator
- ALVO 85.98
- ARDT 0.00
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
About ARDT ARDENT HEALTH PARTNERS INC
Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services predominantly through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operate across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas.